loader from loading.io

PT 645 - Oli Genn-Bash: Functional Mushrooms, Hype Cycles, and Mycelial Thinking

Psychedelics Today

Release Date: 12/28/2025

PT 645 - Oli Genn-Bash: Functional Mushrooms, Hype Cycles, and Mycelial Thinking show art PT 645 - Oli Genn-Bash: Functional Mushrooms, Hype Cycles, and Mycelial Thinking

Psychedelics Today

(Brighton, UK) joins Joe Moore for a grounded conversation on the boom in functional mushrooms and why the category may be moving too quickly. As the founder of , Oli works with consumers and brands to demystify functional mushrooms, with a focus on education, traceability, and realistic expectations. The conversation begins with a critique of wellness hype cycles. Oli explains how consumer desperation for help with anxiety, sleep, stress, and cognition can create an opening for a rapid wave of products that are not always grounded in careful sourcing or clear science. Using as a case...

info_outline
PT 644 - Tricia Eastman: Seeding Consciousness, Ancestral Wisdom, and Psychedelic Initiation show art PT 644 - Tricia Eastman: Seeding Consciousness, Ancestral Wisdom, and Psychedelic Initiation

Psychedelics Today

In this live episode, joins to discuss . She explains why many Indigenous initiatory systems begin with consultation and careful assessment of the person, often using divination and lineage-based diagnostic methods before anyone enters ceremony. Eastman contrasts that with modern frameworks that can move fast, rely on short trainings, or treat the medicine as a stand-alone intervention. Early Themes: Ritual, Preparation, and the Loss of Container Eastman describes her background, including ancestral roots in Mexico and her later work at Crossroads Ibogaine in Mexico, where she supported...

info_outline
PT 643 - Logan Davidson - American Ibogaine, State Strategy, and the Future of Psychedelic Policy show art PT 643 - Logan Davidson - American Ibogaine, State Strategy, and the Future of Psychedelic Policy

Psychedelics Today

Logan Davidson joins the show to talk about the fast-moving world of Ibogaine in American and why state-based leadership is shaping the future of psychedelic reform. Davidson is the executive director of , the legislative director at , and a key strategist behind Texas’ landmark interest in ibogaine research. He also advises for . His work sits at the intersection of science, policy, and lived experience, and this conversation offers a clear look into what is happening right now. Early Themes: The Rise of State Advocacy Davidson explains how he entered politics at nineteen and how his...

info_outline
PT 642 - Michael Sapiro PhD - Truth Medicine, Psychedelics, and Living Your Truth show art PT 642 - Michael Sapiro PhD - Truth Medicine, Psychedelics, and Living Your Truth

Psychedelics Today

In this episode, joins Kyle Buller to explore truth, healing, and psychedelic-assisted psychotherapy through the lens of his new book, . A clinical psychologist, ordained Zen Buddhist monk, retreat leader, and fellow at the Institute of Noetic Sciences, he blends Buddhist psychology, trauma work, and consciousness studies. The discussion focuses on how people discover and live their truth, and why that truth becomes the core medicine in healing. Early in the Podcast with Michael Sapiro describes how years of clinical work and retreat facilitation shaped his understanding of healing....

info_outline
PT 641 - Joe Moore & Kyle Buller - Holotropic Breathwork, Somatics, and Foundations for Psychedelic Work show art PT 641 - Joe Moore & Kyle Buller - Holotropic Breathwork, Somatics, and Foundations for Psychedelic Work

Psychedelics Today

sits at the center of this wide ranging conversation between Psychedelics Today co-founders Joe Moore and Kyle Buller. Drawing from decades of personal practice and assorted types of breathwork facilitation, they explore how breathwork methods from the Grof lineage including can prepare people for psychedelic work, support difficult journeys, and deepen integration over time. Kyle shares how his near death experience, somatic training, and breathwork facilitation shaped this new course on breathwork foundations, while Joe reflects on how reading Dr Stanislav Grof and years of experience in...

info_outline
PT 640 - Alexander Beiner - Psychedelics, Culture, and the Games We Play show art PT 640 - Alexander Beiner - Psychedelics, Culture, and the Games We Play

Psychedelics Today

Alexander joins Psychedelics Today to explore how psychedelics, culture, and power shape each other. A writer, facilitator, and co founder of the conference and the media platform , he has spent years thinking about how psychedelic experiences ripple into politics, economics, conflict, and community. In this episode, he and Joe trace the path from early internet forums to today’s psychedelic renaissance, and ask what it would mean to bring a truly psychedelic perspective into our institutions. Beiner is less interested in psychedelics as a niche medical tool and more interested in how they...

info_outline
PT 639 - Evelyn Eddy Shoop PMHNP-BC: Lived Experience, Qualitative Data, and the Future of Psychedelic Care show art PT 639 - Evelyn Eddy Shoop PMHNP-BC: Lived Experience, Qualitative Data, and the Future of Psychedelic Care

Psychedelics Today

Overview Evelyn Eddy Shoop PMHNP-BC joins Psychedelics Today to share her journey from Division I athlete to psychiatric mental health nurse practitioner and psilocybin research participant. In this conversation, she explains how sports injuries, OCD, and intensive treatment led her into psychiatry and eventually into a psilocybin clinical trial at Yale. Her story weaves together lived experience, clinical training, and a call for more humane systems of care and better qualitative data in psychedelic science. Early Themes: Injury, OCD, and Choosing Psychiatry Early in the episode, Evelyn...

info_outline
PT 638 - Dr Jason Konner - Psychedelic Oncologist show art PT 638 - Dr Jason Konner - Psychedelic Oncologist

Psychedelics Today

In this episode, Joe Moore sits down with Dr. Jason Konner, a longtime oncologist who recently left his full-time clinical role at to devote himself to the emerging intersection of cancer care and psychedelics. Dr Konner shares how, after more than two decades treating people, he hit a wall. The accumulated grief, constant exposure to death, and intensity of oncology left him deeply , though he didn’t have that language for it at the time. A chance moment in a yoga class, overhearing someone say “ retreat” just before he was scheduled for hernia surgery, became the turning point....

info_outline
PT 637 - Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of Integration show art PT 637 - Genesee Herzberg — Ketamine Truths, MDMA Hopes, and the Work of Integration

Psychedelics Today

Clinical psychologist Dr. Genesee Herzberg joins Kyle to reflect on two decades in trauma work and 15 years inside the psychedelic ecosystem—from early MAPS conferences to running Sage Integrative Health. She traces how personal psychedelic experiences set her on a path of service, research at CIIS on MDMA-assisted therapy, and hands-on roles with MAPS: Zendo Project harm reduction, adherence rating, and ultimately serving as an MDMA therapist in clinical trials. Today she leads Sage, an integrative clinic (psychotherapy, psychiatry, bodywork, acupuncture, and functional nutrition) focused...

info_outline
PT 636 - Dr. Ros Watts – Building Communities and Connection show art PT 636 - Dr. Ros Watts – Building Communities and Connection

Psychedelics Today

Clinical psychologist joins to share insights from her decade of work with and her evolving focus on community-based integration. As the former Clinical Lead for , Dr. Watts witnessed how psychedelic experiences can foster profound feelings of — to self, others, and nature — yet also how that connection can fade without ongoing support. In this conversation, she reflects on what years of research have taught her about connectedness as both a healing mechanism and a human need. She explores how can transform fleeting psychedelic breakthroughs into lasting change, and why community is...

info_outline
 
More Episodes

Oli Genn-Bash (Brighton, UK) joins Joe Moore for a grounded conversation on the boom in functional mushrooms and why the category may be moving too quickly. As the founder of The Fungi Consultant, Oli works with consumers and brands to demystify functional mushrooms, with a focus on education, traceability, and realistic expectations.

The conversation begins with a critique of wellness hype cycles. Oli explains how consumer desperation for help with anxiety, sleep, stress, and cognition can create an opening for a rapid wave of products that are not always grounded in careful sourcing or clear science. Using lion’s mane as a case study, he contrasts popular cognitive claims with traditional use, arguing that the most useful path forward is to slow down, get more literate about mechanisms, and build a market that can sustain trust over time.

Systems and Culture

Oli describes how individual health is inseparable from community realities, including food access, class dynamics, and what wellness advice can sound like when it lands from a place of privilege. They discuss mycelial thinking as a practical framework for collaboration and resource-sharing, and why mushrooms tend to attract unusually generous “teach everyone” communities.

They also explore the role of mushrooms in meaning-making and consciousness. Oli shares personal reflections on mushrooms as allies, the felt sense of “agency” in psychedelic experiences, and how those experiences can encourage behavioral change without forcing it. The conversation touches on alcohol culture in the UK and the possibility of non-alcoholic alternatives, including how functional mushrooms, microdosing, and other botanicals can support social confidence and energy for some people.

Finally, they look ahead at fungal innovation beyond supplements: materials, soil health, regenerative approaches, bioremediation, and what the broader psychedelic movement might learn from fungi’s patience, symbiosis, and balance.


Key themes and takeaways

1) Why functional mushrooms feel “too fast” right now

Oli argues that functional mushrooms have accelerated into a high-pressure wellness marketplace, with brands rushing products to market and consumers struggling to determine what is legitimate, traceable, and effective. He draws parallels to the UK CBD market, describing how oversaturation and inconsistent quality can erode trust and collapse prices.

2) Lion’s mane, tradition, and mechanism

Lion’s mane is a useful example of how modern marketing can outrun nuance. Oli notes the gap between popular cognitive claims and traditional use, and points toward the gut-brain axis as one plausible bridge that requires more careful explanation and patience.

3) “Functional mushrooms” as a frame

Oli prefers the term functional mushrooms over medicinal mushrooms, emphasizing systems-level support rather than a pharmaceutical model. He describes a view of health that starts on the cellular level and asks what supports function, resilience, and prevention.

4) Health is individual and collective

Oli speaks candidly about barriers to wellness in the UK, including food poverty, access to education about cooking, and how class dynamics shape what health messaging sounds like. The broader point is structural: it is difficult to talk about supplements without considering the baseline conditions of daily life.

5) Mycelial thinking, futures work, and collaboration

The conversation highlights “mycelial thinking” as more than a metaphor. Oli describes collaborations in futures-oriented communities and how fungal logic can inform collaboration, non-zero-sum outcomes, and resource sharing.

6) Mushroom culture and the instinct to share

Joe notes how strikingly generous mushroom communities can be, especially around cultivation and identification. Oli agrees and adds a provocative angle: the possibility of “agency” in fungi and a sense that mushrooms invite humans into relationship, curiosity, and participation.

7) Alcohol culture and alternatives

Oli reflects on nearly three years without alcohol and describes how functional mushrooms and other botanicals can support mood, energy, and social confidence for some people. They also discuss the realities of events culture, including the need for more inclusive non-alcoholic options and sensitivity to addiction histories.

8) The next 10 years of fungi

They look at the expansion of fungi into materials, fashion, regenerative agriculture, soil health, and bioremediation. Oli emphasizes balance: fungal innovations are promising, but scaling and real-world constraints matter.

9) What the psychedelic movement can learn from fungi

Oli critiques extractive, capital-driven dynamics in the psychedelic ecosystem and suggests fungi offer a different ethic: patience, humility, symbiosis, and realism about parasitism and imbalance.